Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura
Silvia Ferrari(Baxter (Austria)), Friedrich Scheiflinger(Baxter (Austria)), Barbara Plaimauer(Baxter (Austria)), Peter L. Turecek(University of Vienna), Louis M. Aledort(Icahn School of Medicine at Mount Sinai), Kristina Palavra(Baxter (Austria)), Johanna A. Kremer Hovinga(University of Bern), B. Gruber(Baxter (Austria)), Caroline Cromwell(Icahn School of Medicine at Mount Sinai), Coralie Caron, Paul Knöbl(Medical University of Vienna), Hanspeter Rottensteiner(Baxter (Austria))
Cited by 61
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
|Journal of Pharmaceutical Sciences|2016|707
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613